Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H20N2O2 |
| Molecular Weight | 260.3315 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1(CCCN2CC(N=C12)C3=CC=CC=C3)OC
InChI
InChIKey=DWIKEPVFPTUJQU-UHFFFAOYSA-N
InChI=1S/C15H20N2O2/c1-18-15(19-2)9-6-10-17-11-13(16-14(15)17)12-7-4-3-5-8-12/h3-5,7-8,13H,6,9-11H2,1-2H3
| Molecular Formula | C15H20N2O2 |
| Molecular Weight | 260.3315 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Oxamisole (previously known as PR 879-317A), a selective immunomodulatory agent that was studied for the treatment of viral infections. Experiments on mice have shown that antiviral properties of oxamisole were mediated through the immunomodulatory effects of this compound on the immune system. However, further development of this drug was discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Immunomodulator effects on the Friend virus infection in genetically defined mice. | 1993-06-23 |
|
| The immunological profile of a new immunomodulatory agent, oxamisole. | 1988 |
|
| Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A). | 1987-07 |
|
| PR 879-317A enhances in vitro immune activity of peripheral blood mononuclear cells from patients with Down syndrome. | 1987 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:19:38 GMT 2025
by
admin
on
Wed Apr 02 09:19:38 GMT 2025
|
| Record UNII |
MW5753V737
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
204053
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY | |||
|
C053269
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY | |||
|
C174725
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY | |||
|
SUB09493MIG
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110715
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY | |||
|
6238
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY | |||
|
DTXSID00869331
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY | |||
|
100000083562
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY | |||
|
99258-56-7
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY | |||
|
MW5753V737
Created by
admin on Wed Apr 02 09:19:38 GMT 2025 , Edited by admin on Wed Apr 02 09:19:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |